1. Home
  2. RCUS vs COUR Comparison

RCUS vs COUR Comparison

Compare RCUS & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • COUR
  • Stock Information
  • Founded
  • RCUS 2015
  • COUR 2012
  • Country
  • RCUS United States
  • COUR United States
  • Employees
  • RCUS N/A
  • COUR N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • COUR Computer Software: Prepackaged Software
  • Sector
  • RCUS Health Care
  • COUR Technology
  • Exchange
  • RCUS Nasdaq
  • COUR Nasdaq
  • Market Cap
  • RCUS 1.4B
  • COUR 1.3B
  • IPO Year
  • RCUS 2018
  • COUR 2021
  • Fundamental
  • Price
  • RCUS $14.15
  • COUR $8.44
  • Analyst Decision
  • RCUS Buy
  • COUR Buy
  • Analyst Count
  • RCUS 12
  • COUR 13
  • Target Price
  • RCUS $34.50
  • COUR $11.17
  • AVG Volume (30 Days)
  • RCUS 583.4K
  • COUR 1.2M
  • Earning Date
  • RCUS 02-19-2025
  • COUR 01-30-2025
  • Dividend Yield
  • RCUS N/A
  • COUR N/A
  • EPS Growth
  • RCUS N/A
  • COUR N/A
  • EPS
  • RCUS N/A
  • COUR N/A
  • Revenue
  • RCUS $263,000,000.00
  • COUR $684,374,000.00
  • Revenue This Year
  • RCUS $127.65
  • COUR $11.01
  • Revenue Next Year
  • RCUS N/A
  • COUR $6.61
  • P/E Ratio
  • RCUS N/A
  • COUR N/A
  • Revenue Growth
  • RCUS 119.17
  • COUR 12.36
  • 52 Week Low
  • RCUS $13.51
  • COUR $6.29
  • 52 Week High
  • RCUS $20.31
  • COUR $20.73
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 39.00
  • COUR 51.44
  • Support Level
  • RCUS $13.81
  • COUR $8.08
  • Resistance Level
  • RCUS $14.45
  • COUR $8.88
  • Average True Range (ATR)
  • RCUS 0.57
  • COUR 0.30
  • MACD
  • RCUS -0.06
  • COUR -0.03
  • Stochastic Oscillator
  • RCUS 30.40
  • COUR 45.00

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: